Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
Transplantation ; 99(1): 36-40, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25340599

RESUMO

INTRODUCTION: Hepatocyte transplantation could be an alternative to liver transplantation for the treatment of metabolic diseases. However, rodent models have shown that engraftment of transplanted cells in the liver is low and requires deposition of cells in hepatic sinusoids. Splanchnic vasodilatators improved hepatocyte engraftment in a rat model. Therefore, we investigated the effect of glyceryl trinitrate (GTN) on the efficacy of cell engraftment and on liver repopulation in the mdr2-knockout mouse, a model for progressive familial intrahepatic cholestasis type 3. METHODS: Congenic normal mdr2 (+/+) hepatocytes were isolated by two-step collagenase perfusion and transplanted into mdr2(-/-) mice livers through the portal vein in the presence or absence of GTN. Liver repopulation was assessed by immunohistochemistry, and transplanted hepatocyte function was assessed at different times after transplantation by measurement of biliary lipid secretion and quantification of fibrosis. RESULTS: The number of engrafted cells in GTN-treated mice was significantly higher than that in control mice, and transplanted hepatocytes were found in a greater number of distal sinusoids. Levels of phospholipid secretion were significantly higher than those in the control group 3 months after hepatocyte transplantation (18.3 ± 2.3 vs. 5.2 ± 3.9 nmol/min/100 g, P < 0.0001), and the ratio of phospholipids to bile salt was greater (6.8 ± 1.3 vs. 3.2 ± 1.6, P = 0.03). The percentage area of liver fibrosis was also significantly reduced in GTN-treated mice (5.7% ± 2.3% vs. 12.4% ± 2.9%, P = 0.016). CONCLUSION: The use of GTN improves hepatocyte engraftment and correction of metabolic disease in mdr2 (-/-) mice. This approach might be beneficial in hepatocyte transplantation for the treatment of patients with liver diseases.


Assuntos
Subfamília B de Transportador de Cassetes de Ligação de ATP/deficiência , Colestase Intra-Hepática/cirurgia , Hepatócitos/efeitos dos fármacos , Hepatócitos/transplante , Transplante de Fígado/métodos , Nitroglicerina/farmacologia , Subfamília B de Transportador de Cassetes de Ligação de ATP/genética , Subfamília B de Transportador de Cassetes de Ligação de ATP/metabolismo , Animais , Ácidos e Sais Biliares/metabolismo , Proliferação de Células/efeitos dos fármacos , Células Cultivadas , Colestase Intra-Hepática/genética , Colestase Intra-Hepática/metabolismo , Modelos Animais de Doenças , Hepatócitos/metabolismo , Cirrose Hepática/genética , Cirrose Hepática/metabolismo , Cirrose Hepática/cirurgia , Masculino , Camundongos Knockout , Fosfolipídeos/metabolismo , Fatores de Tempo , Membro 4 da Subfamília B de Transportadores de Cassetes de Ligação de ATP
2.
Presse Med ; 41(9 Pt 1): 841-6, 2012 Sep.
Artigo em Francês | MEDLINE | ID: mdl-22727982

RESUMO

Fraud is only a part of misconduct in research. Very few French research Institutions have a scientific integrity office, and their prevention. The Institut national de la santé et de la recherche médicale (Inserm) has created a "Scientific Integrity delegation". Scientific Integrity is an international concern. Scientific Integrity is closely linked to organisation, management and evaluation of all research activities.


Assuntos
Fraude/prevenção & controle , Má Conduta Científica , Academias e Institutos , Comitês Consultivos , Autoria , Políticas Editoriais , Ética em Pesquisa , Europa (Continente) , França , Humanos , Cooperação Internacional , Plágio , Pesquisa/normas , Projetos de Pesquisa/normas
3.
Exp Biol Med (Maywood) ; 234(9): 1102-8, 2009 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-19546353

RESUMO

Cell transplantation has become a major focus in biomedical research. However, efficient engraftment in solid tissues remains a challenge. Hepatocyte growth factor (HGF) signaling increases survival, proliferation, migration, and invasion of many cell types through Met, its cell surface receptor. Therefore, activation of this signaling pathway may improve the ability of many cells to be transplanted. We constructed a constitutively activated form of Met (Tpr-Met) fused to the protein transduction domain of HIV-TAT to activate the HGF/Met pathway for a few hours following cell injection. Matrix-assisted refolding was used to renature TAT-Tpr-Met protein, which was efficiently delivered into cells and recapitulated several biological functions of Met in vitro. Furthermore, treatment of hepatic progenitors with this molecule for one hour before transplantation significantly improved engraftment efficiency (31% untreated cells, 58% treated cells). These findings suggest that the transient transfer of Tpr-Met may provide a new approach to increase the proportion of successfully engrafted cells.


Assuntos
Fator de Crescimento de Hepatócito/metabolismo , Hepatócitos/fisiologia , Receptores de Fatores de Crescimento/metabolismo , Transdução de Sinais , Transplante de Células-Tronco/métodos , Células-Tronco/fisiologia , Animais , Linhagem Celular , Camundongos , Receptores de Fatores de Crescimento/genética , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismo , Produtos do Gene tat do Vírus da Imunodeficiência Humana/genética , Produtos do Gene tat do Vírus da Imunodeficiência Humana/metabolismo
4.
Med Clin (Barc) ; 130(1): 17-9, 2008 Jan 19.
Artigo em Espanhol | MEDLINE | ID: mdl-18221641

RESUMO

BACKGROUND AND OBJECTIVE: The Alagille syndrome (AS) is characterized by biliary ductopenia and abnormalities of heart, eyes, face, bones, kidneys and brain with a dominant inheritability. Mutations of Jagged 1 gene are observed in individuals with the full syndrome and/or relatives with little or no phenotypic features. Prognosis of patients depends on the hepatic and cardiovascular involvement. PATIENTS AND METHOD: We present the cases of a woman and her 2 male nephews with AS. We performed a molecular study of the Jagged 1 gene in family members with and without the syndrome. RESULTS: The molecular study detected mutations in the position 2785+2 of TAAG (intron 19) of the Jagged 1 gene in 3 relatives with the full syndrome and in 2 other members with a partial syndrome. Other relatives, without mutation, have some of the phenotypic features of it. CONCLUSIONS: We comment on the clinical forms of AS in this family and the detected mutation. Molecular diagnosis allows to make a genetic counsel.


Assuntos
Síndrome de Alagille/diagnóstico , Síndrome de Alagille/genética , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Linhagem , Fenótipo
5.
Med. clín (Ed. impr.) ; 130(1): 17-19, ene. 2008. ilus
Artigo em Es | IBECS | ID: ibc-058477

RESUMO

Fundamento y objetivo: El síndrome de Alagille (SA) se caracteriza por ductopenia biliar y anomalías del corazón, ojos, cara, huesos, riñón y cerebro, junto a una herencia dominante. Las mutaciones del gen Jagged 1 se observan en sujetos con el síndrome completo y/o familiares que tienen pocos o ningún rasgo fenotípico del síndrome. El pronóstico de los pacientes depende de la afectación hepática y cardiovascular. Pacientes y método: Se presentan los casos de una mujer y sus 2 sobrinos (varones) con SA. Se realizó estudio molecular del gen Jagged 1 en los miembros de la familia con síndrome y sin él. Resultados: El estudio molecular detectó mutaciones en la posición 2785+2 del TAAG (intrón 19) del gen Jagged 1 en 3 familiares que tienen el síndrome completo y en otros 2 casos con síndrome parcial. Otros familiares, sin mutación, presentan alguno de los rasgos fenotípicos del síndrome. Conclusiones: Se comentan las formas clínicas del SA en esta familia y la mutación encontrada. El diagnóstico molecular permite realizar un consejo genético


Background and objective: The Alagille syndrome (AS) is characterized by biliary ductopenia and abnormalities of heart, eyes, face, bones, kidneys and brain with a dominant inheritability. Mutations of Jagged 1 gene are observed in individuals with the full syndrome and/or relatives with little or no phenotypic features. Prognosis of patients depends on the hepatic and cardiovascular involvement. Patients and method: We present the cases of a woman and her 2 male nephews with AS. We performed a molecular study of the Jagged 1 gene in family members with and without the syndrome. Results: The molecular study detected mutations in the position 2785+2 of TAAG (intron 19) of the Jagged 1 gene in 3 relatives with the full syndrome and in 2 other members with a partial syndrome. Other relatives, without mutation, have some of the phenotypic features of it. Conclusions: We comment on the clinical forms of AS in this family and the detected mutation. Molecular diagnosis allows to make a genetic counsel


Assuntos
Masculino , Feminino , Adulto , Pessoa de Meia-Idade , Humanos , Síndrome de Alagille/genética , Aconselhamento Genético , Mutação , Fácies , Telangiectasia , Icterícia
6.
Hum Mol Genet ; 16(22): 2683-92, 2007 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-17720887

RESUMO

Heterozygous mutations in JAGGED1, encoding a single-pass transmembrane ligand for the Notch receptors, cause Alagille syndrome (AGS), a polymalformative disorder affecting the liver, heart, eyes and skeleton and characterized by a peculiar facies. Most of the JAGGED1 mutations generate premature termination codons, and as a result, two pathogenic mechanisms causing AGS have been proposed: haploinsufficiency or a dominant-negative effect of putative truncated proteins. To determine whether missense or protein-truncating mutations in JAGGED1 can lead to the synthesis and function of abnormal proteins, we performed cell culture experiments. We showed that human JAGGED1 undergoes a metalloprotease-dependent cleavage resulting in the shedding of its extracellular domain and that this domain seems able to fulfill a biological function in vitro, probably by antagonizing Notch signaling. Moreover, the soluble form of JAGGED1 was able to compete with the transmembrane ligand. Mutant proteins with missense or nonsense mutations were synthesized and gave rise to a chord-like phenotype and a migration defect when expressed by stably transfected cells. These chord-like structures were similar to the phenotype exhibited by fibroblasts isolated from a fetus with a protein-truncating mutation. Results obtained from Notch signaling inhibition and Notch reporter assays showed that this chord-like phenotype, exhibited by mutant JAGGED1 transfectants, may result from an inhibitory effect on Notch signaling. Altogether, our results favor a dominant-negative mechanism of some JAGGED1 mutations in AGS.


Assuntos
Síndrome de Alagille/metabolismo , Proteínas de Ligação ao Cálcio/fisiologia , Peptídeos e Proteínas de Sinalização Intercelular/fisiologia , Proteínas de Membrana/fisiologia , Mutação/genética , Receptores Notch/genética , Transdução de Sinais , Animais , Western Blotting , Células COS , Diferenciação Celular , Linhagem Celular , Movimento Celular , Chlorocebus aethiops , Imunofluorescência , Humanos , Proteína Jagged-1 , Luciferases/metabolismo , Camundongos , Células NIH 3T3 , Receptores Notch/metabolismo , Proteínas Serrate-Jagged , Transfecção
7.
Am J Kidney Dis ; 49(5): 705-9, 2007 May.
Artigo em Inglês | MEDLINE | ID: mdl-17472854

RESUMO

Alagille syndrome (AGS; Online Mendelian Inheritance in Man no. 118450) is a multisystem autosomal dominant disorder with highly variable expression characterized by chronic cholestasis caused by a paucity of interlobular bile ducts, skeletal abnormalities, peculiar facies, ocular abnormalities, and cardiovascular disorders. AGS is diagnosed almost exclusively in children in the setting of predominant liver manifestations or, more rarely, in their adult relatives. We report 2 patients in whom AGS was diagnosed in adulthood during the workup of renal disease in the absence of a well-defined familial history. Renal disease caused by AGS probably is underdiagnosed in adult patients.


Assuntos
Síndrome de Alagille/diagnóstico , Síndrome de Alagille/cirurgia , Adulto , Síndrome de Alagille/complicações , Feminino , Humanos , Falência Renal Crônica/complicações , Falência Renal Crônica/diagnóstico , Falência Renal Crônica/cirurgia , Fatores de Tempo
8.
J Pediatr Gastroenterol Nutr ; 44(4): 453-8, 2007 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-17414143

RESUMO

OBJECTIVES: Progressive familial intrahepatic cholestasis (PFIC) and to a lesser extent, Alagille syndrome, often lead to end-stage liver disease during childhood. We report our experience of DNA-based prenatal diagnosis of PFIC1-3 and Alagille syndrome. PATIENTS AND METHODS: Four molecular antenatal diagnoses were performed in 3 PFIC families and 17 in 11 Alagille syndrome families. DNA was isolated from chorionic villus or cultured amniocyte samples from women, without pregnancy complications. RESULTS: All four foetuses with a family history of PFIC1, 2, or 3 were heterozygous for an ATP8B1, ABCB11, or ABCB4 mutation and pregnancies were continued. Three of the infants were healthy after birth, and 1 premature infant, who had an ABCB4 mutation, experienced transient neonatal cholestasis. Among the families with a history of de novo JAG1 mutation, none of the foetuses was mutated, versus 40% of those with a history of familial mutation. Of 4 pregnant women with a JAG1-mutated foetus, 3 cut short their pregnancy and 1 gave birth to a child with overt Alagille syndrome. CONCLUSIONS: Molecular antenatal diagnosis of PFIC1-3 and Alagille syndrome is reliable because clinical outcome after birth corresponded to molecular foetal data.


Assuntos
Colestase Intra-Hepática/diagnóstico , Colestase Intra-Hepática/genética , Síndrome de Alagille/diagnóstico , Síndrome de Alagille/genética , Amostra da Vilosidade Coriônica , DNA/análise , Feminino , Aconselhamento Genético , Humanos , Mutação , Gravidez
10.
Transplantation ; 82(8): 1067-73, 2006 Oct 27.
Artigo em Inglês | MEDLINE | ID: mdl-17060856

RESUMO

BACKGROUND: Hepatocyte transplantation could be an alternative to whole liver transplantation for the treatment of metabolic liver diseases. However, the results of clinical investigations suggest that the number of engrafted hepatocytes was insufficient to correct metabolic disorders. This may partly result from a lack of proliferation of transplanted hepatocytes. In rodents, portal ligation enhances hepatocyte engraftment after transplantation. We investigated the effects of partial portal ligation and embolization on engraftment and proliferation of transplanted hepatocytes in primates. METHODS: Hepatocyte autotransplantation was performed in Macaca monkeys. The left lateral lobe was resected for hepatocyte isolation. The first group of monkeys underwent surgical ligation of the left and right anterior portal branches; in the second group, the same portal territories were obstructed by embolization with biological glue. To evaluate the proportion of cell engraftment hepatocytes were Hoechst-labeled and transplanted via the portal vein. Cell proliferation was measured by BrdU incorporation. RESULTS: Hepatocyte proliferation was induced by both procedures but it was significantly higher after partial portal embolization (23.5% and 11.2% of dividing hepatocytes on days 3 and 7) than after ligation (3% and 0.8%). Hepatocytes engrafted more efficiently after embolization than after ligation. They proliferated and participated to liver regeneration representing 10% of the liver mass on day seven and their number remained constant on day 15. CONCLUSIONS: These data suggest that partial portal embolization of the recipient liver improves engraftment of transplanted hepatocytes in a primate preclinical model providing a new strategy for hepatocyte transplantation.


Assuntos
Transplante de Células/métodos , Embolização Terapêutica , Hepatócitos/citologia , Veia Porta/patologia , Animais , Bromodesoxiuridina/farmacologia , Proliferação de Células , Hepatócitos/metabolismo , Fígado/patologia , Hepatopatias/terapia , Regeneração Hepática , Macaca , Primatas , Resultado do Tratamento
12.
J Inherit Metab Dis ; 29(2-3): 436-41, 2006.
Artigo em Inglês | MEDLINE | ID: mdl-16763915

RESUMO

Transplantation of allogeneic or genetically modified autologous hepatocytes may be an alternative to whole-liver transplantation for the treatment of hereditary metabolic liver diseases. Human hepatocytes have already been transplanted in patients, demonstrating the safety and feasibility of both approaches. Although a few cases of allogeneic transplantation have resulted in long-term engraftment and function, only a partial and transient correction of the disease was achieved. This may partly result from a lack of proliferation of transplanted cells. In rodents, transplanted hepatocytes do not proliferate in adult quiescent livers and repopulate recipient livers only when they display a proliferative advantage over resident hepatocytes. Most of these models are not transposable to humans, however. Our aim is to develop preclinical approaches to hepatocyte transplantation in nonhuman primates. We have defined a strategy that increases the engraftment efficiency of transplanted hepatocytes by inducing their proliferation together with that of resident hepatocytes. We have also immortalized simian fetal hepatic progenitor cells and shown that these cells do not proliferate in situ after transplantation into the livers of immunodeficient mice. By contrast early human hepatoblasts repopulate mouse livers more efficiently. However, if we consider the number of cells to be transplanted (one to several billion), the means of expanding and differentiating stem or progenitor cells other than hepatocytes will have to be determined prior to envisaging treating patients.


Assuntos
Hepatócitos/transplante , Regeneração Hepática , Células-Tronco Adultas/transplante , Animais , Diferenciação Celular , Linhagem Celular , Proliferação de Células , Células-Tronco Fetais/transplante , Humanos , Hepatopatias/cirurgia , Camundongos , Modelos Animais , Primatas , Ratos
13.
Nano Lett ; 5(12): 2578-85, 2005 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-16351219

RESUMO

In the present work, we report the effects of C(60)-pretreatments on acute carbon tetrachloride intoxication in rats, a classical model for studying free-radical-mediated liver injury. Our results show that aqueous C(60) suspensions prepared without using any polar organic solvent not only have no acute or subacute toxicity in rodents but they also protect their livers in a dose-dependent manner against free-radical damage. To be sure, according to histopathological examinations and biological tests, pristine C(60) can be considered as a powerful liver-protective agent.


Assuntos
Antioxidantes/administração & dosagem , Fulerenos/administração & dosagem , Cirrose Hepática Experimental/patologia , Cirrose Hepática Experimental/prevenção & controle , Fígado/efeitos dos fármacos , Fígado/patologia , Animais , Antioxidantes/química , Tetracloreto de Carbono , Relação Dose-Resposta a Droga , Fulerenos/efeitos adversos , Fulerenos/química , Fulerenos/farmacocinética , Fígado/metabolismo , Cirrose Hepática Experimental/induzido quimicamente , Taxa de Depuração Metabólica , Nanoestruturas/efeitos adversos , Ratos , Distribuição Tecidual , Resultado do Tratamento
14.
Hum Genet ; 116(6): 445-53, 2005 May.
Artigo em Inglês | MEDLINE | ID: mdl-15772854

RESUMO

Heterozygous mutations in JAGGED1 (JAG1), encoding a ligand for Notch receptors, have been identified in patients with Alagille syndrome (AGS). These mutations map to the extracellular and transmembrane domains of JAG1, giving rise in 70% cases to a premature termination codon (PTC). Although haploinsufficiency has been hypothesised as the main mechanism of AGS, a dominant negative effect of truncated forms of Serrate/Jagged has been suggested. Only few studies of the mutant mRNAs and proteins from AGS patients have been performed to elucidate the molecular mechanisms of the disease. To gain insight into the stability of mutant mRNAs, we studied transcripts from five livers and 24 lymphoblastoid cell lines (LCLs) of AGS patients. Mutant JAG1 transcripts were recovered (albeit in different relative amounts) from RNAs with missense mutations (five) or in-frame deletions (two), and from all but two of the 21 with PTCs. In addition, results from LCL RNAs correlated well with results from liver RNAs. Mutant transcripts were also recovered from tissues of a 23-week-old AGS foetus with a PTC mutation. This suggests that most mutant transcripts with PTCs escape nonsense-mediated mRNA decay (NMD) and could lead to the synthesis of soluble forms of JAG1. Production of a truncated protein was indeed observed after transfection of COS cells with a mutant JAG1 cDNA. In conclusion, mutant JAG1 transcripts are present in LCLs, livers and tissues of AGS patients, whatever the mutation type, and mutant proteins can be produced, suggesting a dominant negative effect of some mutant proteins as another molecular mechanism of AGS.


Assuntos
Síndrome de Alagille/genética , Proteínas de Membrana/genética , Mutação , Síndrome de Alagille/embriologia , Alelos , Animais , Sequência de Bases , Células COS , Proteínas de Ligação ao Cálcio , Linhagem Celular , Chlorocebus aethiops , Humanos , Peptídeos e Proteínas de Sinalização Intercelular , Proteína Jagged-1 , Linfócitos , Dados de Sequência Molecular , Proteínas Serrate-Jagged , Transfecção
15.
Gastroenterology ; 127(5): 1386-90, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15521008

RESUMO

BACKGROUND AND AIMS: Most human and animal cholestatic disorders are associated with changes in hepatocyte cytoskeleton and tight junctions (TJs). These changes are usually secondary and nonspecific phenomena, both in intra- and extrahepatic cholestasis. Recently, missense mutations in TJ protein 2 (ZO-2) have been identified in patients with familial hypercholanemia. In the liver, TJs separate bile flow from plasma and are composed of strands of claudins and occludin. We previously assigned a syndrome associating ichthyosis and neonatal sclerosing cholangitis (NISCH syndrome) to chromosome 3q27-q28. We considered claudin-1 to be a strong candidate gene based on its mapping to the minimum interval and on the expression pattern of the mouse ortholog. METHODS: The 4 exons and intron-exon junctions of claudin-1 gene were amplified using standard polymerase chain reaction protocols and specific primers. Western blot analysis on cultured fibroblasts and immunohistochemistry on liver tissue section were performed using rabbit anti-claudin-1 antibodies. RESULTS: We described in 4 patients, of 2 inbred kindred of Moroccan origin, a 2-bp deletion (200-201 TT) in exon 1 of the claudin-1 gene arising in a premature stop codon and resulting in total absence of claudin-1 protein in the liver and skin. CONCLUSIONS: Lack of claudin-1 in NISCH syndrome may lead to increased paracellular permeability between epithelial cells. Bile duct injury may be related to the absence of claudin-1 expression in cholangiocytes. Our observation, in conjunction with ZO-2-associated hypercholanemia, emphasizes the role played by TJ components in hereditary cholestasis.


Assuntos
Colangite Esclerosante/genética , Cromossomos Humanos Par 3/genética , Ictiose/genética , Proteínas de Membrana/genética , Mutação , Colangite Esclerosante/complicações , Colangite Esclerosante/congênito , Mapeamento Cromossômico , Claudina-1 , Feminino , Humanos , Ictiose/complicações , Masculino , Linhagem , Síndrome
17.
Cancer Gene Ther ; 10(11): 840-9, 2003 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-14605670

RESUMO

Engineered retroviruses are widely used vectors for cancer gene therapy approaches. However, the ability to target cells of therapeutic interest while controlling the expression of the transferred genes would improve both the efficiency and the safety of viral vectors. In this study, we investigated the ability of a retroviral amphotropic envelope displaying single-chain variable-fragment (scFv) directed against the c-Met receptor, to target the entry of recombinant retroviruses to human hepatocarcinoma cells. Four single-chain antibody fragments directed against the c-Met receptor were generated and inserted into the viral envelope protein as an N-terminal fusion. The modified envelopes were incorporated into virus particles and one of the chimeric viruses, 3D6-Env, transduced preferentially human hepatoma cells rather than proliferating human hepatocytes. In another construct, the urokinase cleavage site was inserted between the scFv moiety and the envelope. Chimeric scFv-urokinase-Env viruses transduced hepatoma cells with a similar efficiency to that of the control virus and their infectivity in human hepatocytes remained low. These results indicate that amphotropic retroviruses with engineered envelopes to display scFv directed against the c-Met receptor can efficiently and selectively deliver genes into hepatoma cells.


Assuntos
Carcinoma Hepatocelular/genética , Técnicas de Transferência de Genes , Região Variável de Imunoglobulina/genética , Neoplasias Hepáticas/genética , Proteínas Proto-Oncogênicas c-met/imunologia , Anticorpos/genética , Anticorpos/imunologia , Carcinoma Hepatocelular/virologia , Expressão Gênica , Vetores Genéticos/genética , Vetores Genéticos/metabolismo , Hepatócitos/fisiologia , Hepatócitos/virologia , Humanos , Engenharia de Proteínas/métodos , Retroviridae/genética , Retroviridae/patogenicidade , Transdução Genética , Células Tumorais Cultivadas , Ativador de Plasminogênio Tipo Uroquinase/genética , Vírion
18.
J Hepatol ; 39(3): 447-52, 2003 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12927934

RESUMO

BACKGROUND/AIMS: Progressive familial intrahepatic cholestasis characterized by normal serum gamma-glutamyltransferase activity can be due to mutations in familial intrahepatic cholestasis type 1 (FIC1) (ATP8B1), a gene expressed in several organs. In some cases, it is associated with extrahepatic features. We searched for FIC1 mutations and analyzed the outcome of extrahepatic features after liver transplantation in two children with this form of progressive familial intrahepatic cholestasis associated with chronic unexplained diarrhea and short stature. METHODS: FIC1 sequence was determined after polymerase chain reaction (PCR) of genomic lymphocyte DNA and/or reverse transcription-PCR of liver or lymphocyte RNA. RESULTS: A homozygous amino acid change deletion was found in one child. The second child harboured compound heterozygous missense and nonsense mutations. In both children, despite successful liver transplantation, evolution (follow-up: 9.5-11 years) was characterized by exacerbation of diarrhea and no catch-up of stature growth, and appearance of liver steatosis. CONCLUSIONS: Progressive familial intrahepatic cholestasis characterized by normal serum gamma-glutamyltransferase activity and extrahepatic features corresponds to progressive familial intrahepatic cholestasis type 1. Extrahepatic symptomatology is not corrected or may be aggravated by liver transplantation, impairing life quality.


Assuntos
Adenosina Trifosfatases/genética , Colestase Intra-Hepática/complicações , Colestase Intra-Hepática/fisiopatologia , Diarreia/fisiopatologia , Fígado Gorduroso/etiologia , Transplante de Fígado/efeitos adversos , Mutação , Sequência de Aminoácidos , Estatura , Colestase Intra-Hepática/genética , Colestase Intra-Hepática/cirurgia , Códon sem Sentido , Diarreia/etiologia , Progressão da Doença , Deleção de Genes , Crescimento , Heterozigoto , Homozigoto , Humanos , Lactente , Masculino , Mutação de Sentido Incorreto
19.
Pediatrics ; 111(1): 167-70, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12509572

RESUMO

OBJECTIVE: Spontaneous intracranial bleeding is now a widely recognized complication and cause of mortality in patients with Alagille syndrome. The pathogenesis of intracranial bleeding in these patients remains unclear. The aim of the study was to look for other sites of bleeding in these patients that could suggest a factor of multiorgan morbidity. METHODS: The records of 174 patients with Alagille syndrome were reviewed, and 38 (22%) patients without liver failure who experienced hemorrhage that led to a drop in hemoglobin level of at least 3 g/dL or to blood transfusion were identified. RESULTS: In 38 patients, 49 bleeding episodes occurred at a median age of 3.75 years (range: 1 month-27 years). Seventeen patients had 23 episodes of spontaneous bleeding; 21 patients bled during surgery or other medical procedures, and 5 among these 21 patients also had a spontaneous bleeding episode. Nine patients bled at least twice. Median platelets count and prothrombin time were normal. Severe cholestasis existed in 33 patients. One patient has a deletion of the 20p12 region, and 13 of 17 patients studied have a JAGGED1 mutation. Blood transfusion was necessary in 23 patients. Eight patients died secondary to bleeding (4 after surgery, 2 after gastrointestinal bleeding, 1 after needle liver biopsy, and 1 after intracranial bleeding). CONCLUSION: These results suggest that patients with Alagille syndrome are at special risk for bleeding; this should be taken into account before deciding on an invasive procedure. The mechanism of the bleeding is still unclear; the role of hypercholesterolemia cannot be excluded, but it may be speculated that JAGGED1 signaling abnormalities may impair the hemostatic function.


Assuntos
Síndrome de Alagille/epidemiologia , Hemorragia/epidemiologia , Adolescente , Adulto , Criança , Pré-Escolar , Comorbidade , Feminino , Humanos , Lactente , Hemorragias Intracranianas/epidemiologia , Hemorragias Intracranianas/mortalidade , Masculino , Estudos Retrospectivos , Taxa de Sobrevida
20.
Indian J Pediatr ; 69(9): 815-8, 2002 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-12420916

RESUMO

Alagille syndrome (AGS) was described more than 35 years ago as a genetic entity characterised by five major features: chronic cholestasis owing to paucity of interlobular bile ducts; peripheral pulmonary stenosis; butterfly like vertebral arch defect; posterior embryotoxon and peculiar facies. AGS has long been said to have a relative good prognosis but overall survival at twenty years averages 70%. Complex congenital heart disease and hepatic disease with or without liver transplantation contribute significantly to mortality. JAGGED1 has been identified as a responsible gene by demonstration of mutations in AGS patients. Studies of JAGGED1 expression pattern demonstrate that minor features and almost all the elements in the long list of manifestations described in AGS patients are not coincidental. This suggests that Alagille syndrome definition may be revisited in the light of JAGGED1 mutations.


Assuntos
Síndrome de Alagille/diagnóstico , Síndrome de Alagille/epidemiologia , Síndrome de Alagille/terapia , Criança , Pré-Escolar , Progressão da Doença , Feminino , Humanos , Incidência , Índia/epidemiologia , Lactente , Recém-Nascido , Masculino , Fatores de Risco , Taxa de Sobrevida
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...